Mohamed Aseafan

6PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Panel data analysisMajor global burdens of diseasePsychosocial aspects of childbirth and perinatal mental healthNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Immune Checkpoint Inhibitor-Related Pneumonitis in Renal Cell Carcinoma: Clinical Features, Mechanisms, and Lessons from Lung Cancer.

|Jul 31, 2026
Estimating the budget impact of introducing dostarlimab as first line in treating endometrial cancer in Saudi Arabia.

|Jan 05, 2026
Nationwide Prevalence of Hepatocellular Carcinoma in Saudi Arabia: A Population-Based Analysis for 2021.

Edward B De Vol, Shouki Bazarbashi, Mohamed Aseafan

|Dec 15, 2025
Treatment Outcome and Chemoresistance-Related Factors of Low-Risk Gestational Trophoblastic Neoplasia: Results From a Tertiary Care Center in Saudi Arabia.

Mohamed Aseafan, Bader Alshamsan, Inaam Ahmed Ibrahim

|Mar 14, 2024
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study.

Shouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan

|Apr 07, 2023
Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre.

Shouki Bazarbashi, Mohamed Aseafan, Tasnim Elgazzar

Pageof 1

Frequent Collaborators

4 joint publications

Shouki Bazarbashi

2 joint publications

Abdulrahman Alghabban

2 joint publications

Bader Alshamsan

1 joint publications

Tasnim Elgazzar